Knight Therapeutics Inc.
KHTRF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $1 | $1 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -18.7% | 21.9% | -9.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 33.2% | 41.8% | 39.6% | 41.7% |
| EBITDA | $0 | -$0 | $0 | $0 |
| % Margin | 15% | -1% | 14.7% | 25.1% |
| Net Income | -$0 | -$0 | $0 | $0 |
| % Margin | -3.1% | -11.8% | 2.5% | 11.1% |
| EPS Diluted | -0.027 | -0.13 | 0.02 | 0.11 |
| % Growth | 79% | -750% | -81.8% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | $0 |